VIVO Cannabis Inc. V.PDA

Very Impressive Quarter for Long Term Goals

[LongTermWinner]

Revenue up 79% YoY in the same span that SGA expenses dropped 18%. The 19% Quaterly increase in medicinal patients is huge as well, their focus on build long lasting patient relationships is proving worthwhile. We knew the 68% Ontario market share already, but doesn't make it any less impressive. EBITDA gap is narrowing, with front loaded 2020 expenses meant to launch long term gains. Most of the negative cash flow is from paying down $10m in debt at a discount.

Still have about $2m difference to make up to become profitable. At the rate of growth by Vivo right now they're coming out about even in Q3 and are profitable in Q4. With EU-GMP certification looming and their foray into beverages with Vertosa, this is looking like it has immense runway for growth in 2020 and into 2021. Doubt the SP stays in this range for long with how close they are to take off.

Well done Vivo, good luck longs.